These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 2678834)

  • 21. [Treatment of advanced ovarian cancer with cis-dichlorodiammine platinum (CDDP) as single agent or cddp in combination with adriamycin (ADM)].
    Nishimura H; Yamada T; Hagio Y; Inoue T; Tsunawaki A; Yakushiji M; Kato T
    Gan To Kagaku Ryoho; 1983 Apr; 10(4 Pt 1):938-43. PubMed ID: 6683483
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Experiences with PAC and PEC polychemotherapy in the treatment of advanced and recurrent breast cancers].
    Werner A; Heuer J; Schulz BO; Diedrich K; Oberheuser F; Krebs D
    Zentralbl Gynakol; 1988; 110(10):603-10. PubMed ID: 3165577
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Significance of second look surgery in the therapy of ovarian cancer].
    Sasaki H; Ochiai K; Terashima Y
    Gan No Rinsho; 1990 Aug; 36(10):1174-8. PubMed ID: 2214157
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Subrenal capsule assay as a predictor of clinical response of ovarian cancer to chemotherapy: Part II.
    Mäenpää J
    Obstet Gynecol; 1985 Nov; 66(5):714-8. PubMed ID: 3903584
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ICON 2 and ICON 3 data in previously untreated ovarian cancer: results to date.
    Harper P
    Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-23-S15-25. PubMed ID: 9346217
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cisplatin and cyclophosphamide in early epithelial ovarian carcinoma.
    Chiara S; Conte PF; Bruzzone M; Falcone A; Sertoli MR; Carnino F; Mossetti C; Iura R; Durando C; Guercio E
    Chemioterapia; 1987 Oct; 6(5):380-3. PubMed ID: 3427698
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Cytoreductive surgery plus combined chemotherapy for the treatment of advanced ovarian cancer].
    Li M; Huang X
    Zhonghua Fu Chan Ke Za Zhi; 1996 Oct; 31(10):621-3. PubMed ID: 9275460
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Advanced stage clear-cell epithelial ovarian cancer: the Hellenic Cooperative Oncology Group experience.
    Pectasides D; Fountzilas G; Aravantinos G; Kalofonos C; Efstathiou H; Farmakis D; Skarlos D; Pavlidis N; Economopoulos T; Dimopoulos MA
    Gynecol Oncol; 2006 Aug; 102(2):285-91. PubMed ID: 16516283
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Topotecan versus treosulfan, an alkylating agent, in patients with epithelial ovarian cancer and relapse within 12 months following 1st-line platinum/paclitaxel chemotherapy. A prospectively randomized phase III trial by the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group (AGO-OVAR).
    Meier W; du Bois A; Reuss A; Kuhn W; Olbricht S; Gropp M; Richter B; Lück HJ; Kimmig R; Pfisterer J
    Gynecol Oncol; 2009 Aug; 114(2):199-205. PubMed ID: 19446314
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Initial results with PAC polychemotherapy in the treatment of advanced recurrent breast cancers].
    Schulz BO; Oberheuser F; Krebs D
    Zentralbl Gynakol; 1985; 107(3):184-6. PubMed ID: 4039095
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Toxicity and efficacy of chemotherapy dependent on circadian time of cytostatic drug administration].
    Zuchowska-Vogelgesang B; Pernal J; Zemełka T
    Przegl Lek; 1996; 53(12):870-3. PubMed ID: 9163011
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intraperitoneal cisplatin and intravenous paclitaxel in the treatment of epithelial ovarian cancer patients with a positive second look.
    Makhija S; Sabbatini P; Aghajanian C; Venkatraman E; Spriggs DR; Barakat R
    Gynecol Oncol; 2000 Oct; 79(1):28-32. PubMed ID: 11006026
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Re-treatment of patients with recurrent epithelial ovarian cancer with cisplatin-based chemotherapy.
    Gershenson DM; Kavanagh JJ; Copeland LJ; Stringer CA; Morris M; Wharton JT
    Obstet Gynecol; 1989 May; 73(5 Pt 1):798-802. PubMed ID: 2704508
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intraperitoneal versus intravenous cisplatin in combination with intravenous cyclophosphamide and epidoxorubicin in optimally cytoreduced advanced epithelial ovarian cancer: a randomized trial of the Gruppo Oncologico Nord-Ovest.
    Gadducci A; Carnino F; Chiara S; Brunetti I; Tanganelli L; Romanini A; Bruzzone M; Conte PF
    Gynecol Oncol; 2000 Feb; 76(2):157-62. PubMed ID: 10637064
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of advanced epithelial ovarian cancer using cisplatin, adriamycin and cytoxan--the Indiana University experience.
    Ehrlich CE; Einhorn L; Stehman FB; Blessing J
    Clin Obstet Gynaecol; 1983 Aug; 10(2):325-35. PubMed ID: 6688562
    [No Abstract]   [Full Text] [Related]  

  • 36. [Treatment of ovarian cancer].
    Kato T; Nishimura H
    Gan No Rinsho; 1989 Jan; Spec No():392-8. PubMed ID: 2464708
    [No Abstract]   [Full Text] [Related]  

  • 37. Schedule-dependent effectiveness of ADM and multiple cycles of DDP on a murine reticulum sarcoma.
    Leonetti C; Zupi G; Calabresi F; Greco C
    Anticancer Res; 1990; 10(1):45-8. PubMed ID: 2185688
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical study of combination chemotherapy with CDDP, ADM and CPM for ovarian cancer].
    Kobayashi H; Maeda M; Hayata T; Kawashima Y
    Nihon Gan Chiryo Gakkai Shi; 1988 Apr; 23(4):829-36. PubMed ID: 3204307
    [No Abstract]   [Full Text] [Related]  

  • 39. Recurrent ovarian carcinoma: retreatment utilizing combination chemotherapy including cis-diamminedichloroplatinum in patients previously responding to this agent.
    Seltzer V; Vogl S; Kaplan B
    Gynecol Oncol; 1985 Jun; 21(2):167-76. PubMed ID: 3921437
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The second look at tumors of the ovary. Our experience].
    Sanlorenzo M; Vigezzi P; Caldarola F; Allone T
    Minerva Chir; 1988 Sep; 43(18):1477-9. PubMed ID: 2465506
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.